Comparison of Intravitreal Triamcinolone Acetonide With Photodynamic Therapy and Intravitreal Bevacizumab with Photodynamic Therapy for Retinal Angiomatous Proliferation

American Journal of Ophthalmology

Volumn 149, Issue 3, 2010, Pages

  Saito, Masaaki ^a   Shiragami, Chieko ^b   Shiraga, Fumio ^b   Kano, Mariko ^a   Iida, Tomohiro ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE; VERTEPORFIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUSEN; ENDOPHTHALMITIS; EYE INFLAMMATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTRAOCULAR HYPERTENSION; MALE; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA DISEASE; RETINA EDEMA; RETINA HEMORRHAGE; RETINA MACULA CYSTOID EDEMA; RETINAL ANGIOMATOUS PROLIFERATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 76749110756     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.09.016     Document Type: Article

References (41)

1. Yannuzzi L.A., Negrão S., Iida T., et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 21 (2001) 416-434
2. Freund K.B., Ho I.V., Barbazetto I.A., et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 28 (2008) 201-211
3. Cohen S.Y., Creuzot-Garcher C., Darmon J., et al. Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration. Br J Ophthalmol 91 (2007) 1173-1176
4. Maruko I., Iida T., Saito M., Nagayama D., and Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144 (2007) 15-22
5. Hartnett M.E., Weiter J.J., Staurenghi G., and Elsner A.E. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 103 (1996) 2042-2053
6. Bottoni F., Massacesi A., Cigada M., Viola F., Masicco I., and Staurenghi G. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 123 (2005) 1644-1650
7. Bressler N.M. Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease. Arch Ophthalmol 123 (2005) 1741-1743
8. Slakter J.S., Yannuzzi L.A., Schneider U., et al. Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 107 (2000) 742-753
9. Kuroiwa S., Arai J., Gaun S., Iida T., and Yoshimura N. Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation. Retina 23 (2003) 417-420
10. Sakimoto S., Gomi F., Sakaguchi H., and Tano Y. Recurrent retinal angiomatous proliferation after surgical ablation. Am J Ophthalmol 139 (2005) 917-918
11. Shiragami C., Iida T., Nagayama D., Baba T., and Shiraga F. Recurrence after surgical ablation for retinal angiomatous proliferation. Retina 27 (2007) 198-203
12. Boscia F., Furino C., Sborgia L., Reibaldi M., and Sborgia C. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 138 (2004) 1077-1079
13. Silva R.M., Cachulo M.L., Figueira J., de Abreu J.R., and Cunha-Vaz J.G. Chorioretinal anastomosis and photodynamic therapy: a two-year follow-up study. Graefes Arch Clin Exp Ophthalmol 245 (2007) 1131-1139
14. Kvanta A., Algvere P.V., Berglin L., and Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37 (1996) 1929-1934
15. Kliffen M., Sharma H.S., Mooy C.M., Kerkvliet S., and de Jong P.T. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 81 (1997) 154-162
16. Oh H., Takagi H., and Takagi C. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 40 (1999) 1891-1898
17. Penfold P.L., Wen L., Madigan M.C., King N.J., and Provis J.M. Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci 43 (2002) 3125-3130
18. Hori Y., Hu D.E., Yasui K., Smither R.L., Gresham G.A., and Fan T.P. Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants. Br J Pharmacol 118 (1996) 1584-1591
19. Freund K.B., Klais C.M., Eandi C.M., et al. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 124 (2006) 487-492
20. Rouvas A.A., Papakostas T.D., Vavvas D., et al. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina 29 (2009) 536-544
21. Krzystolik M.G., Afshari M.A., Adamis A.P., et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120 (2002) 338-346
22. Gragoudas E.S., Adamis A.P., Cunningham Jr. E.T., Feinsod M., Guyer D.R., and VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
23. Spaide R.F., Laud K., Fine H.F., et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26 (2006) 383-390
24. Rosenfeld P.J., Brown D.M., Heier J.S., et al., MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
25. Brown D.M., Kaiser P.K., Michels M., et al. ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1432-1444
26. Dhalla M.S., Shah G.K., Blinder K.J., Ryan Jr. E.H., Mittra R.A., and Tewari A. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration. Retina 26 (2006) 988-993
27. Ladas I.D., Kotsolis A.I., Papakostas T.D., Rouvas A.A., Karagiannis D.A., and Vergados I. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration. Retina 27 (2007) 891-896
28. Kaiser P.K., Registry of Visudyne AMD Therapy Writing Committee, Boyer D.S., Garcia R., et al. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Ophthalmology 116 (2009) 747-755
29. Saito M., Shiragami C., Shiraga F., Nagayama D., and Iida T. Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 146 (2008) 935-941
30. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP Report 1. Arch Ophthalmol 117 (1999) 1329-1345
31. Tatar O., Adam A., Shinoda K., et al. Influence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degeneration. Retina 27 (2007) 713-723
32. Tatar O., Adam A., Shinoda K., et al. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy. Am J Ophthalmol 142 (2006) 95-104
33. Borrillo J.L., Sivalingam A., Martidis A., and Federman J.L. Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 121 (2003) 558-561
34. Meyerle C.B., Freund K.B., Iturralde D., et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 27 (2007) 451-457
35. Joeres S., Heussen F.M., Treziak T., Bopp S., and Joussen A.M. Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245 (2007) 1597-1602
36. Okamoto N., Tobe T., Hackett S.F., et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 151 (1997) 281-291
37. Fung A.E., Lalwani G.A., Rosenfeld P.J., et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143 (2007) 566-583
38. Kiss C.G., Geitzenauer W., Simader C., et al. Evaluation of ranibizumab-induced changes in high-resolution optical coherence tomographic retinal morphology and their impact on visual function. Invest Ophthalmol Vis Sci 50 (2009) 2376-2383
39. Rouvas A.A., Papakostas T.D., Ladas I.D., and Vergados I. Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a combination of photodynamic therapy with an intravitreal injection of bevacizumab for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 246 (2008) 315-318
40. Spaide R.F., Sorenson J., and Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110 (2003) 1517-1525
41. Bhavsar A.R., Ip M.S., Glassman A.R., and DRCRnet and the SCORE Study Groups. The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol 144 (2007) 454-456